TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 33 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,038,000 | +132.2% | 286,918 | +28.2% | 0.00% | – |
| Q2 2021 | $2,170,000 | +9.3% | 223,801 | +21.1% | 0.00% | – |
| Q1 2021 | $1,986,000 | -69.3% | 184,856 | -58.0% | 0.00% | – |
| Q4 2020 | $6,469,000 | +244.6% | 439,812 | +232.9% | 0.00% | – |
| Q3 2020 | $1,877,000 | +75.1% | 132,100 | -0.3% | 0.00% | – |
| Q2 2020 | $1,072,000 | +50.8% | 132,500 | -24.7% | 0.00% | – |
| Q1 2020 | $711,000 | +35450.0% | 176,042 | +8702.1% | 0.00% | – |
| Q4 2019 | $2,000 | – | 2,000 | +700.0% | 0.00% | – |
| Q2 2019 | $0 | – | 250 | +150.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -83.3% | 0.00% | – |
| Q4 2018 | $1,000 | -80.0% | 600 | -21.4% | 0.00% | – |
| Q2 2018 | $5,000 | +150.0% | 763 | +90.8% | 0.00% | – |
| Q3 2017 | $2,000 | -71.4% | 400 | -63.6% | 0.00% | – |
| Q1 2017 | $7,000 | -92.1% | 1,100 | -93.0% | 0.00% | – |
| Q4 2016 | $89,000 | +1383.3% | 15,800 | +3850.0% | 0.00% | – |
| Q3 2016 | $6,000 | – | 400 | +19900.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 2 | -99.8% | 0.00% | – |
| Q1 2016 | $7,000 | +75.0% | 800 | +179.7% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 286 | -6.8% | 0.00% | – |
| Q3 2015 | $4,000 | – | 307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|